Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mira Ko
OpenAlex ID:
A5005564800
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient–derived xenograft mouse models
2021
·
Tiziana Vaisitti
, Francesca Arruga
, et al.
·
Blood
·
96
PDF
Vls-101 Is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Richter's Syndrome (RS)
2019
·
Tiziana Vaisitti
, Katti Jessen
, et al.
·
Blood
·
14
Abstract LB187: Investigating the roles of ROR1/2 in non-small cell lung carcinoma NSCLC and potential therapeutic applications
2024
·
Wen-An Pan
, Xin Guo
, et al.
·
Cancer Research
Show more works
View as search
Works count:
3
Citation count:
110
H-index:
2
I10-index:
2
Year
Topic
Type
